Skip to content
Forensic Analysis · Healthcare Providers & Services · as of Nov 8, 2026

Cryo Cell International Inc (CCEL)

A forensic read on Cryo Cell International Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective
Forensic grade
Clean
Earnings quality
1
Forensic signals
-1.3%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Cryo Cell International Inc earns a C (Mixed — selective) forensic quality grade. 1 forensic signal was flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

0.9%
FY2025
Return on invested capital. Return on invested capital is 0.9% in the latest fiscal year, against -24.3% in FY2023, having run between -24.3% and 5.5% across FY2023–FY2025 with no direction held. After-tax operating profit was ($10M) in FY2023 and $381,091 in FY2025, with operating income at -39.3% of revenue in FY2023, 10.9% in FY2024 and 1.5% in FY2025. The capital base behind it went from $40M in FY2023 to $42M in FY2025 (+5%), while the revenue it carried went from $31M to $32M. FY2023's operating profit carried a $4M asset write-down that took about 7.4 points off that year's return, and FY2025's carried a $4M asset write-down that took about 8.2 points off the latest; so, net of each other, the two charges take about 0.8 points off the +25.2-point change across FY2023–FY2025. A non-cash write-down lowers the reported return in the year it lands.

Key fundamentals

Latest Revenue$31.6M
Revenue Growth YoY-1.3%
Revenue CAGR (2yr)+0.4%
Net Margin-7.7%
Free Cash Flow$5.2M

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Cryo Cell International Inc's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.